{"title": "A one-enzyme RT-qPCR assay for SARS-CoV-2, and procedures for reagent production", "body": "\uf0b7 20X EvaGreen solution \uf0b7 4 mM deoxyribonucleotides (dNTP) \uf0b7 5M Betaine \uf0b7 20 U/\u00b5L SUPERase.In RNase inhibitor \uf0b7 5 U/\u00b5L Taq DNA polymerase \uf0b7 0.2 mg/ml RTX polymerase b \uf0b7 Nuclease-free water \uf0b7 qPCR tubes or plates c \uf0b7 Real-time PCR machine c \uf0b7 Cold-block or ice \uf0b7 Barrier tips a Individual primer and probe stocks or pre-made primer-probe mixes for CDC N1, N2 and N3 assays ( Table 1) available from Integrated DNA Technologies may be used. b RTX polymerase with proofreading capability (RTX), and RTX polymerase without proofreading capability (RTX Exo-) have been compared. c LightCycler96 real-time PCR machine and 96-well plates with optical plastic film cover designed for use with LightCycler platform were used for these experiments. Table 1 . CDC TaqMan qRT-PCR primers and probes for SARS-CoV-2 (adapted from https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html).\n\nDescription nucleocapsid phosphoprotein (N) gene near the 3'-end of the ~30 kb viral genome. In particular, N1 primers (Table 1 ) amplify a 71 nt long region from position 28287 to 28358 of the genome (GenBank Accession No. MN985325.1). The N2 primers produce a 66 bp amplicon from the genomic position 29164 to 29230. Meanwhile, the N3 primers amplify a 71 nt long region from genomic position 28681 to 28752. All reaction mixes were assembled on a cold-block and directly transferred to a real-time PCR machine programmed to cycle through the steps depicted in Table  3 . Melt curve analysis was included after PCR amplification in order to distinguish target amplicons from spurious products. 97 \u00b0C 1 sec Continuous c a Assay time may be reduced by shortening reverse transcription step (Step 1) to 15 min and the following denaturation step ( Step 2) to 2 min. Figure 1 . CDC SARS-CoV-2 N1, N2, and N3 RT-qPCR assays performed using indicated copies of synthetic RNA and RTX DNA polymerase. Panels A, B, and C depict N1, N2, and N3 assays measured in real-time using EvaGreen dye. Amplification curves from reactions containing 100,000 (black traces), 10,000 (blue traces), 1,000 (red traces), and 100 (pink traces) copies of SARS-CoV-2 synthetic N RNA are depicted. Negative control reactions either contained no templates (gray traces) or contained 100,000 copies of synthetic N RNA from MERS-CoV (green traces). Panels D, E, and F depict melting peaks of amplicons determined using the 'Tm calling' analysis in the LightCycler96 software. Average Cq values of all assays are tabulated. Figure 2 . CDC SARS-CoV-2 N1, N2, and N3 RT-qPCR assays performed using indicated copies of synthetic RNA and RTX Exo-DNA polymerase. Panels A, B, and C depict N1, N2, and N3 assays measured in realtime using EvaGreen dye. Amplification curves from reactions containing 100,000 (black traces), 10,000 (blue traces), 1,000 (red traces), and 100 (pink traces) copies of SARS-CoV-2 synthetic N RNA are depicted. Negative control reactions either contained no templates (gray traces) or contained 100,000 copies of synthetic N RNA from MERS-CoV (green traces). Panels D, E, and F depict melting peaks of amplicons determined using the 'Tm calling' analysis in the LightCycler96 software. Average Cq values of all assays are tabulated.\n\nThese results demonstrate that RTX DNA polymerase alone, with or without proofreading capability, can support dye-based RT-qPCR analyses. In our hands the full-length RTX DNA polymerase was slightly better than the Exo-version, especially in the N3 assay.\n\nIn order to perform TaqMan RT-qPCR we developed a one-pot two enzyme system comprising RTX and Taq DNA polymerases. TaqMan qRT-PCR reaction set up shown in Table 4 was used for assembling CDC SARS-CoV-2 N1, N2, and N3 assays using either RTX buffer or ThermoPol buffer. Control reactions lacking RTX polymerase were set up using the same recipe except RTX was replaced with water. All reaction mixes were assembled on a cold-block and directly transferred to a real-time PCR machine programmed to cycle through the steps depicted in Table 5 . . CDC SARS-CoV-2 N1, N2, and N3 TaqMan RT-qPCR assays performed in 1X ThermoPol buffer using indicated copies of synthetic RNA and RTX or RTX Exo-and Taq DNA polymerases. Panels A, B, and C depict TaqMan assays containing both RTX and Taq DNA polymerases. Panels D, E, and F depict TaqMan assays containing only Taq DNA polymerase. Panels G, H, and I depict TaqMan assays containing RTX Exoand Taq DNA polymerases. Amplification curves from reactions containing 100,000 (black traces), 10,000 (blue traces), 1,000 (red traces), and 100 (pink traces) copies of SARS-CoV-2 synthetic N RNA are depicted. Negative control reactions either contained no templates (gray traces) or contained 100,000 copies of synthetic N RNA from MERS-CoV (green traces). Cq values of all assays are tabulated.\n\n. CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . Figure 4 . CDC SARS-CoV-2 N1, N2, and N3 TaqMan RT-qPCR assays performed in 1X RTX buffer using indicated copies of synthetic RNA and RTX or RTX Exo-and Taq DNA polymerases. Panels A, B, and C depict TaqMan assays containing RTX and Taq DNA polymerases. Panels D, E, and F depict TaqMan assays containing RTX Exo-and Taq DNA polymerases. Amplification curves from reactions containing 100,000 (black traces), 10,000 (blue traces), 1,000 (red traces), and 100 (pink traces) copies of SARS-CoV-2 synthetic N RNA are depicted. Negative control reactions either contained no templates (gray traces) or contained 100,000 copies of synthetic N RNA from MERS-CoV (green traces). Cq values of all assays are tabulated.\n\nTo compare the RTX-based TaqMan qRT-PCR with qRT-PCR performed using commercial master mix, duplicate reactions ( Table 6 ) were set up using TaqPath\u2122 1-Step RT-qPCR Master Mix, CG (Thermo Fisher Scientific, Waltham, MA, USA). All reactions were assembled on cold block and then incubated at room temperature (25 \u00b0C benchtop) for 2 min prior to being loaded on a realtime PCR machine set to cycle through the steps indicated in Table 7 .\n\n. CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint Table 6 . CDC N1, N2, N3 TaqMan qRT-PCR assay set up using commercial qRT-PCR master mix Volume (\u00b5L) RNA sample 5 6.7 \u00b5M Forward PCR primer 1.5 6.7 \u00b5M Reverse PCR primer 1.5 1.7 \u00b5M TaqMan probe 1.5 4X TaqPath TM master mix 5 Water 5.5 Total reaction volume 20 The results with either a viral RT (in TaqPath TM commercial mastermix) or RTX are summarized in Table 8 . As can be seen, RTX-based TaqMan assays are of comparable sensitivity and specificity to the gold standard TaqPath assay. While all three RTX-based TaqMan assays performed in ThermoPol buffer consistently yielded Cq values, these were somewhat delayed compared to Cq values obtained with the commercial TaqPath\u2122 Master Mix. In contrast, RTX-based TaqMan assays when executed in RTX buffer yielded Cq values that were closer to Cq values obtained with the commercial mastermix. Summary of assay performance Overall, RTX performs well either as a single enzyme for RT-qPCR with intercalating dyes, such as EvaGreen, or as the RT component of a TaqMan based assay. At the lowest RNA concentrations examined (100 copies), the gold standard TaqPath assay general gave a signal at a Cq value of ca. 32. The more robust full-length RTX on its own actually performed slightly better, with Cq values typically from 29-30 (although the N3 primer set gives higher signal and higher background). When used as a substitute for a viral RT, RTX is slightly less sensitive overall, with Cq values typically from 32-35.\n\n. CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint\n\nPurification of RTX For sites wishing to produce their own RTX, the following protocol can be used. Perform IMAC column purification in a cold room or allow gravity flow to occur in a refrigerator. Prepare Ni-NTA agarose columns with final column volume (CV) of 1 mL. Apply the clarified lysate from 1 L of expressed culture to a previously equilibrated column and collect the flow-through. Wash column with 20 CV Equilibration Buffer and collect the flow-through. Wash column with 5 CV Wash Buffer and collect flow-through. Elute RTX from column with 5 mL Elution Buffer and transfer to a dialysis cassette with appropriate molecular weight cut-off. Dialyze eluate into 2 L of Ni-NTA Dialysis Buffer for 3-4 hours at 4\u02daC. Then dialyze eluate into a second 2 L of Ni-NTA Dialysis Buffer overnight at 4\u02daC.\n\nDialyzed eluate was then passed over an equilibrated 5 mL heparin column (HiTrap\u2122 Heparin HP) and eluted along a sodium chloride gradient (100 mM to 2 M NaCl). The peak corresponding to RTX or its variants could be expected between 40-60% Buffer B. RTX fractions were collected, pooled, and dialyzed into 2 L Heparin Dialysis Buffer for 3-4 hours. Then dialysis cassettes were transferred into 2 L Final Dialysis Buffer overnight where it is expected that the protein sample . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint volume will decrease significantly. Following the final dialysis, protein sample was recovered and protein concentration was determined before storing at -20\u02daC.\n\nA similar protocol should work for Taq and other thermostable polymerases, but may require different dialysis and storage buffers.\n\nSummary and opportunities for distribution By obtaining a RTX expression vector and purifying the thermostable reverse transcriptase it should prove possible to carry out RT-qPCR reactions with a sensitivity similar to that already observed for approved kits, with few or no false positive results. The sequence information for plasmids for RTX [pET_RTX-6xHis] and its exonuclease deficient variant, RTX(exo-) [pET_RTX(exo -)-6xHis], bearing a C-terminal 6xHis tags can be found in the Supplemental Information. These plasmids will be uploaded to Addgene in short order, or can be obtained by directly contacting the Ellington lab, via a.maranhao@utexas.edu. Figure S1 . The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint /created_by=\"User\" /label=\"bla (AmpR)\" rep_origin 1042..1555 /created_by=\"User\" /modified_by=\"User\" /label=\"M13 ori\" rep_origin 1666..2254 /created_by=\"User\" /modified_by=\"User\" /label=\"pMB1 ori\" gene complement(2623..2814) /created_by=\"User\" /label=\"rop\" gene complement(3371..4453) /created_by=\"User\" /label=\"lacI\" promoter 5637..5654 /created_by=\"User\" /label=\"T7 Promoter\" operon 5656..5680 /created_by=\"User\" /label=\"lacO\" misc_feature 5722..5727 /created_by=\"User\" /modified_by=\"User\" /label=\"NdeI\" CDS 5725..8085 /created_by=\"User\" /modified_by=\"User\" /label=\"RTX\" misc_difference 5836..5838 /created_by=\"User\" /label=\"F38L\" misc_difference 6013..6015 /created_by=\"User\" /label=\"R97M\" misc_difference 6076..6078 /created_by=\"User\" /modified_by=\"User\" /label=\"K118I\" misc_difference 6133..6135 /created_by=\"User\" /label=\"M137L\" misc_difference 6865..6867 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint /created_by=\"User\" /label=\"R381H\" misc_difference 6874..6876 /created_by=\"User\" /label=\"Y384H\" misc_difference 6889..6891 /created_by=\"User\" /label=\"V389I\" misc_difference 7120..7122 /created_by=\"User\" /label=\"K466R\" misc_difference 7201..7203 /created_by=\"User\" /label=\"Y493L\" misc_difference 7264..7266 /created_by=\"User\" /label=\"T514I\" misc_difference 7285..7287 /created_by=\"User\" /label=\"I521L\" misc_difference 7483..7485 /created_by=\"User\" /label=\"F587L\" misc_difference 7714..7716 /created_by=\"User\" /label=\"E664K\" misc_difference 7855..7857 /created_by=\"User\" /label=\"G711V\" misc_difference 7927..7929 /created_by=\"User\" /label=\"N735K\" misc_difference 8026..8028 /created_by=\"User\" /label=\"W768R\" misc_feature 8047..8052 /created_by=\"User\" /label=\"XhoI\" misc_feature 8053..8058 /created_by=\"User\" /label=\"BamHI\" terminator 8104..8226 /created_by=\"User\" /label=\"T7 Tphi transcription terminator\" The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint 5221 ttccccaggc atcaaataaa acgaaaggct cagtcgaaag actgggcctt tcgttttatc 5281 tgttgtttgt cggtgaacgc tctcctgagt aggacaaatc cgccgggagc ggatttgaac 5341 gttgcgaagc aacggcccgg agggtggcgg gcaggacgcc cgccataaac tgccaggaat 5401 taattcccca ggcatcaaat aaaacgaaag gctcagtcga aagactgggc ctttcgtttt 5461 atctgttgtt tgtcggtgaa cgctctcctg agtaggacaa atccgccggg agcggatttg 5521 aacgttgcga agcaacggcc cggagggtgg cgggcaggac gcccgccata aactgccagg 5581 aattggggat cggaattaat tcccggttta aaccggggat ctcgatcccg cgaaattaat 5641 acgactcact ataggggaat tgtgagcgga taacaattcc cctctagaaa taattttgtt 5701 taactttaag aaggagatat acatatgatt cttgacacgg attacatcac ggaagacggc 5761 aagccggtta tccgtatttt caagaaagaa aacggcgaat tcaagattga atacgatcgg 5821 acatttgaac cgtacctgta cgctctcctc aaggatgata gcgcaatcga agaagtgaaa 5881 aaaatcaccg cagagcggca tggcacagtg gtaacagtta agcgggtcga gaaagtgcag 5941 aagaagttct taggccggcc agtcgaagta tggaaattat acttcacaca tccacaggac 6001 gttccggcga tcatggataa gattcgggag catccggcgg taatcgatat ctatgaatac 6061 gatattccgt tcgctattcg ctaccttatt gacaaaggtt tagttccaat ggagggtgat 6121 gaggaactta aactgttagc attcgatatc gaaacacttt atcacgaagg tgaagagttt 6181 gccgaaggtc cgattttaat gatctcgtac gccgatgaag aaggcgcacg cgtaattacg 6241 tggaaaaatg tggacctccc gtacgtagac gtagtgagca ctgagcgcga gatgattaaa 6301 cgtttccttc gggtagtaaa agaaaaagac ccagacgtgc tgattacgta taacggcgac 6361 aactttgatt ttgcctatct caagaagcgt tgcgaaaagt taggcattaa tttcgccctg 6421 ggtcgggacg gttcagagcc gaaaattcag cggatgggcg accgctttgc tgtggaggta 6481 aaaggtcgca tccatttcga tttatatccg gttatccggc gcaccatcaa cttgccgact 6541 tacacacttg aagcagttta cgaagcggtg ttcggccaac caaaagaaaa ggtttatgcc 6601 gaggagatta ccaccgcatg ggaaactggc gaaaacttgg agcgggtggc tcggtattcc 6661 atggaagatg ccaaggtgac ctacgaactg ggcaaagagt ttttaccgat ggaagcacaa 6721 ttaagccgcc ttattggtca gtccctctgg gatgtgtcgc gttcttcaac gggcaattta 6781 gtcgaatggt ttcttcttcg gaaagcgtac gagcgtaacg agcttgctcc aaataagcca 6841 gacgaaaaag aattggctcg gcgccatcag tcacatgagg gcggctacat taaggagcca 6901 gaacggggct tgtgggagaa catcgtctac cttgattttc ggtctcttta tccgtctatt 6961 atcatcacac ataacgtctc gccagatacc ctgaaccgtg aaggctgtaa agaatatgat 7021 gtggcaccac aggtcggcca tcgtttttgt aaagacttcc cgggcttcat tccatctctt 7081 ctgggtgatt tgttagaaga gcgtcaaaag atcaagaaac gtatgaaagc gacaattgac 7141 ccaattgaac gcaaattact tgattaccgt cagcgtgcaa tcaagatcct cgcgaactct 7201 ctgtacggtt attacggcta cgcacgcgcc cggtggtatt gcaaagaatg tgcagaatca 7261 gtcattgctt ggggtcggga gtacctgacc atgacgatta aggaaattga ggagaaatac 7321 ggtttcaagg tcatctatag tgacacggat ggtttctttg caacgattcc aggtgcggac 7381 gcagaaactg taaagaaaaa ggcaatggag ttcttgaagt atattaatgc gaagttgcca 7441 ggcgccctgg aattagagta cgaaggtttt tataagcgtg gcctgttcgt gacaaagaag 7501 aaatacgcgg taattgacga ggaaggcaag atcacaactc gtggcttgga aattgttcgt 7561 cgcgattgga gcgagatcgc aaaggagacc caagctcgtg tgttggaggc cctcctgaag 7621 gatggtgacg tcgaaaaagc cgtacgcatc gttaaggagg ttacagagaa gcttagcaag 7681 tatgaggtcc caccagagaa acttgttatt cataaacaaa tcactcgcga ccttaaagac 7741 tataaggcca ctggtccaca cgtcgccgta gcaaagcggc ttgcggctcg gggcgtcaag 7801 attcggccag gcacggttat tagttacatc gtcctcaaag gctcaggccg gattgttgat . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint 7861 cgcgcgattc catttgatga atttgatccg acgaagcata aatatgatgc ggaatattac 7921 attgaaaaac aggttctgcc ggcggtggag cgcatcttac gtgcgttcgg ctatcgcaag 7981 gaggatttgc ggtaccagaa aactcgtcaa gtcggtttga gtgcccgtct gaagccgaaa 8041 ggtaccctcg agggatccag ccatcaccat caccatcact gataagcggc cgcattgatc 8101 cggctgctaa caaagcccga aaggaagctg agttggctgc tgccaccgct gagcaataac 8161 tagcataacc ccttggggcc tctaaacggg tcttgagggg ttttttgctg aaaggaggaa 8221 ctatatccgg at // Table S1 . GenBank format of pET_RTX-6xHis The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint misc_difference 6013..6015 /created_by=\"User\" /label=\"R97M\" misc_difference 6076..6078 /created_by=\"User\" /modified_by=\"User\" /label=\"K118I\" misc_difference 6133..6135 /created_by=\"User\" /label=\"M137L\" misc_difference 6352..6354 /created_by=\"User\" /label=\"N210D (exo-mutation)\" misc_difference 6865..6867 /created_by=\"User\" /label=\"R381H\" misc_difference 6874..6876 /created_by=\"User\" /label=\"Y384H\" misc_difference 6889..6891 /created_by=\"User\" /label=\"V389I\" misc_difference 7120..7122 /created_by=\"User\" /label=\"K466R\" misc_difference 7201..7203 /created_by=\"User\" /label=\"Y493L\" misc_difference 7264..7266 /created_by=\"User\" /label=\"T514I\" misc_difference 7285..7287 /created_by=\"User\" /label=\"I521L\" misc_difference 7483..7485 /created_by=\"User\" /label=\"F587L\" misc_difference 7714..7716 /created_by=\"User\" /label=\"E664K\" misc_difference 7855..7857 /created_by=\"User\" /label=\"G711V\" misc_difference 7927..7929 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint /created_by=\"User\" /label=\"N735K\" misc_difference 8026..8028 /created_by=\"User\" /label=\"W768R\" misc_feature 8047..8052 /created_by=\"User\" /label=\"XhoI\" misc_feature 8053..8058 /created_by=\"User\" /label=\"BamHI\" terminator 8104..8226 /created_by=\"User\" /label=\"T7 The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint 4381 tcaccacgcg ggaaacggtc tgataagaga caccggcata ctctgcgaca tcgtataacg 4441 ttactggttt cacattcacc accctgaatt gactctcttc cgggcgctat catgccatac 4501 cgcgaaaggt tttgcgccat tcgatggtgt ccgggatctc gacgctctcc cttatgcgac 4561 tcctgcatta ggaagcagcc cagtagtagg ttgaggccgt tgagcaccgc cgccgcaagg 4621 aatggtgcat gccggcatgc cgccctttcg tcttcaagaa ttaattccca attccccagg 4681 catcaaataa aacgaaaggc tcagtcgaaa gactgggcct ttcgttttat ctgttgtttg 4741 tcggtgaacg ctctcctgag taggacaaat ccgccgggag cggatttgaa cgttgcgaag 4801 caacggcccg gagggtggcg ggcaggacgc ccgccataaa ctgccaggaa ttaattcccc 4861 aggcatcaaa taaaacgaaa ggctcagtcg aaagactggg cctttcgttt tatctgttgt 4921 ttgtcggtga acgctctcct gagtaggaca aatccgccgg gagcggattt gaacgttgcg 4981 aagcaacggc ccggagggtg gcgggcagga cgcccgccat aaactgccag gaattaattc 5041 cccaggcatc aaataaaacg aaaggctcag tcgaaagact gggcctttcg ttttatctgt 5101 tgtttgtcgg tgaacgctct cctgagtagg acaaatccgc cgggagcgga tttgaacgtt 5161 gcgaagcaac ggcccggagg gtggcgggca ggacgcccgc cataaactgc caggaattaa 5221 ttccccaggc atcaaataaa acgaaaggct cagtcgaaag actgggcctt tcgttttatc 5281 tgttgtttgt cggtgaacgc tctcctgagt aggacaaatc cgccgggagc ggatttgaac 5341 gttgcgaagc aacggcccgg agggtggcgg gcaggacgcc cgccataaac tgccaggaat 5401 taattcccca ggcatcaaat aaaacgaaag gctcagtcga aagactgggc ctttcgtttt 5461 atctgttgtt tgtcggtgaa cgctctcctg agtaggacaa atccgccggg agcggatttg 5521 aacgttgcga agcaacggcc cggagggtgg cgggcaggac gcccgccata aactgccagg 5581 aattggggat cggaattaat tcccggttta aaccggggat ctcgatcccg cgaaattaat 5641 acgactcact ataggggaat tgtgagcgga taacaattcc cctctagaaa taattttgtt 5701 taactttaag aaggagatat acatatgatt cttgacacgg attacatcac ggaagacggc 5761 aagccggtta tccgtatttt caagaaagaa aacggcgaat tcaagattga atacgatcgg 5821 acatttgaac cgtacctgta cgctctcctc aaggatgata gcgcaatcga agaagtgaaa 5881 aaaatcaccg cagagcggca tggcacagtg gtaacagtta agcgggtcga gaaagtgcag 5941 aagaagttct taggccggcc agtcgaagta tggaaattat acttcacaca tccacaggac 6001 gttccggcga tcatggataa gattcgggag catccggcgg taatcgatat ctatgaatac 6061 gatattccgt tcgctattcg ctaccttatt gacaaaggtt tagttccaat ggagggtgat 6121 gaggaactta aactgttagc attcgatatc gaaacacttt atcacgaagg tgaagagttt 6181 gccgaaggtc cgattttaat gatctcgtac gccgatgaag aaggcgcacg cgtaattacg 6241 tggaaaaatg tggacctccc gtacgtagac gtagtgagca ctgagcgcga gatgattaaa 6301 cgtttccttc gggtagtaaa agaaaaagac ccagacgtgc tgattacgta tgacggcgac 6361 aactttgatt ttgcctatct caagaagcgt tgcgaaaagt taggcattaa tttcgccctg 6421 ggtcgggacg gttcagagcc gaaaattcag cggatgggcg accgctttgc tgtggaggta 6481 aaaggtcgca tccatttcga tttatatccg gttatccggc gcaccatcaa cttgccgact 6541 tacacacttg aagcagttta cgaagcggtg ttcggccaac caaaagaaaa ggtttatgcc 6601 gaggagatta ccaccgcatg ggaaactggc gaaaacttgg agcgggtggc tcggtattcc 6661 atggaagatg ccaaggtgac ctacgaactg ggcaaagagt ttttaccgat ggaagcacaa 6721 ttaagccgcc ttattggtca gtccctctgg gatgtgtcgc gttcttcaac gggcaattta 6781 gtcgaatggt ttcttcttcg gaaagcgtac gagcgtaacg agcttgctcc aaataagcca 6841 gacgaaaaag aattggctcg gcgccatcag tcacatgagg gcggctacat taaggagcca 6901 gaacggggct tgtgggagaa catcgtctac cttgattttc ggtctcttta tccgtctatt 6961 atcatcacac ataacgtctc gccagatacc ctgaaccgtg aaggctgtaa agaatatgat . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.29.013342 doi: bioRxiv preprint"}